Maximus to continue Medicare appeals work

Maximus Inc. will continue processing appeals associated with the Centers for Medicare and Medicaid Services' Medicare Part D prescription drug program under a new three-year contract worth $14 million.

Under the contract, Maximus Federal Services adjudicates appeals from Medicare beneficiaries as a result of denials stemming from a Medicare Advantage-Prescription Drug plan or a stand-alone prescription drug plan, the company said in a news release. Maximus provides the services through its capacity as a qualified independent contractor (QIC) to CMS.

In addition to its Part D QIC responsibilities, the company also handles appeals nationwide for Medicare Part C (Medicare Advantage) and traditional Medicare Part A for the eastern United States.

Maximus has provided Medicare appeals services to CMS since 1989, company officials said.

Maximus Federal Services is part of Maximus Inc., of Reston, Va. The parent company provides program management, consulting and information technology services to government clients.

About the Author

William Welsh is a freelance writer covering IT and defense technology.

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here
close

Trending

  • POWER TRAINING: How to engage your customers

    Don't miss our July 12 Washington Technology Power Training session on Mastering Stakeholder Engagement, where you'll learned the critical skills you need to more fully connect with your customers and win more business. Read More

  • PROJECT 38 PODCAST

    In our latest Project 38 Podcast, editor Nick Wakeman and senior staff writer Ross Wilkers discuss the major news events so far in 2019 and what major trends are on the horizon. Read More

contracts DB

Washington Technology Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.